COPD Inhaler.jpg

We are currently conducting a clinical trial on a medication known as Benralizumab for the treatment of COPD. Benralizumab is currently used for those with asthma and is designed to prevent their immune systems from overreacting and worsening asthmatic attacks.


This trial hopes to show that it can also be beneficial for those with moderate to severe COPD in the same way; by preventing immune system overreaction. Because this is an outcomes study, it is fairly long, estimated at about four years, depending on enrollment, but the input during that time will be fairly low, with a visit to our office about every 2 months.


Participants would be paid $100 per visit and hopefully be a part of helping a life-saving new medication get into the hands of someone who needs it.


All visits are conducted locally in Salt Lake City, Utah.

Benefits of Participating:

Receive compensation up to $100.00 for time and travel per visit.

No cost to participate.
No insurance needed.

Completely voluntary, no obligation to continue.


To Qualify, You Must:

Between 40 and 85 years old.
Be diagnosed with COPD.
Be taking a triple therapy inhaler for treatment.

To find out more call us at (801) 657-3206 or submit the form below. By contacting us, you are in no way obligated to participate. All information submitted is kept strictly confidential and is never shared or sold to third parties.

Coronavirus (COVID-19)

What to expect when visiting Kalo Clinical Research as we begin to resume in-person patient visits. At this time, you can schedule a screening appointment for one of our clinical research trials...continue reading